Choice of antipsychotic treatment by European psychiatry trainees: Are decisions based on evidence?

BMC Psychiatry

Volumn 12, Issue , 2012, Pages

  Jauhar, Sameer ^a   Guloksuz, Sinan ^b   Andlauer, Olivier ^c   Lydall, Greg ^d   Marques, João G ^e   Mendonca, Luis ^f   Dumitrescu, Iolanda ^g   Roventa, Costin ^g   De Vriendt, Nele ^h   Van Zanten, Jeroen ⁱ   Riese, Florian ^j   Nwachukwu, Izu ^k   Nawka, Alexander ^l   Psaras, Raphael ^m   Masson, Neil ⁿ   Krishnadas, Rajeev ^a   Volpe, Umberto ^o  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c University Hospital of Besançon   (France)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^f Centro Hospit alar Psiquiatrico de Lisboa   (Portugal)

^g Hospital Pr Dr Al Obregia   (Romania)

^h Openbaar Psychiatrisch Zorgcentrum Rekem ^*  (Belgium)

ⁱ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^j UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^k ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^l CHARLES UNIVERSITY   (Czech Republic)

^m Psychiatric Hospital of Attika Dafni   (Greece)

ⁿ Wishaw Resource Centre   (United Kingdom)

^o SECOND UNIVERSITY OF NAPLES   (Italy)

more..

Author keywords

Antipsychotics; Decision making; Drug therapy; Efficacy; Evidence based medicine; Psychiatry trainees; Psychosis; Psychotherapy; Treatment

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; ZIPRASIDONE;

ARTICLE; COGNITIVE THERAPY; CROSS-SECTIONAL STUDY; DRUG CHOICE; DRUG EFFICACY; FEMALE; HUMAN; KNOWLEDGE; MALE; MEDICAL DECISION MAKING; MEDICAL STUDENT; PERCEPTION; PRESCRIPTION; PSYCHOSIS; PSYCHOTHERAPY; QUESTIONNAIRE; ADULT; CHILD; CLINICAL PRACTICE; EDUCATION; EUROPE; EVIDENCE BASED MEDICINE; HEALTH CARE SURVEY; PSYCHIATRY; ADVERSE DRUG REACTION; DRUG COST; DRUG PREFERENCE; ELECTROCONVULSIVE THERAPY; EUROPEAN; PROFESSIONAL KNOWLEDGE; PSYCHIATRIC TREATMENT; PSYCHODYNAMIC PSYCHOTHERAPY; STRUCTURED QUESTIONNAIRE; STUDENT ATTITUDE;

ADULT; ANTIPSYCHOTIC AGENTS; CHILD; CROSS-SECTIONAL STUDIES; EUROPE; EVIDENCE-BASED MEDICINE; HEALTH CARE SURVEYS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRY; PSYCHOTIC DISORDERS; QUESTIONNAIRES;

EID: 84859055010     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-12-27     Document Type: Article

References (19)

1. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic, A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988, 45:789-796. 10.1001/archpsyc.1988.01800330013001, 3046553.
2. Foussias G, Remington G. Antipsychotics and schizophrenia: from efficacy and effectiveness to clinical decision-making. Can J Psychiatry 2010, 55:117-125.
3. National Institute of Clinical Excellence National Institute of Clinical Excellence (2002) Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. 2002, National Institute of Clinical Excellence.
4. Jones PB, Barnes TRE, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW. Randomized controlled trial of the effect on Quality of Life of second-vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006, 63:1079-1087. 10.1001/archpsyc.63.10.1079, 17015810.
5. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RSE, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. N Engl J Med 2005, 353:1209-1223. 10.1056/NEJMoa051688, 16172203.
6. Sikich L, Frazier JA, McClellan J, Findling RL, Vitiello B, Ritz L, Ambler D, Puglia M, Maloney AE, Michael E, De Jong S, Slifka K, Noyes N, Hlastala S, Pierson L, McNamara NK, Delporto-Bedoya D, Anderson R, Hamer RM, Lieberman JA. Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study. Am J Psychiatry 2008, 165:1420-1431. 10.1176/appi.ajp.2008.08050756, 18794207.
7. Hamann J, Langer B, Leucht S, Busch R, Kissling W. Medical decision making in antipsychotic drug choice for schizophrenia. Am J Psychiatry 2004, 161:1301-1304. 10.1176/appi.ajp.161.7.1301, 15229068.
8. Taylor M, Brown T. "Do unto others as..."-which treatments do psychiatrists prefer?. Scott Med J 2007, 52:17-19. 10.1258/rsmsmj.52.1.17, 17373419.
9. Bleakley S, Olofinjana O, Taylor D. Which antipsychotics would mental health professionals take themselves?. Psychiatr Bull 2007, 31:94-96.
10. Steinert T. Which neuroleptic would psychiatrists take for themselves or their relatives?. Eur Psychiatry 2003, 18:40-41. 10.1016/S0924-9338(02)00004-4, 12648897.
11. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. , http://www.wma.net/en/30publications/10policies/b3/
12. Sierles FS. How to Do Research With Self-Administered Surveys. Acad Psychiatry 2003, 27:104-113. 10.1176/appi.ap.27.2.104, 12824111.
13. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373:31-41. 10.1016/S0140-6736(08)61764-X, 19058842.
14. Edlinger M, Hofer A, Rettenbacher MA, Baumgartner S, Widschwendter CG, Kemmler G, Neco NA, Fleischhacker WW. Factors influencing the choice of new generation antipsychotic medication in the treatment of patients with schizophrenia. Schizophr Res 2009, 113:246-251. 10.1016/j.schres.2009.06.008, 19595578.
15. Fleischhacker WW, Goodwin GM. Effectiveness as an outcome measure for treatment trials in psychiatry. World Psychiatry 2009, 8:23-27. 2645010, 19293951.
16. Ghaemi SN. The case for, and against, evidence-based psychiatry. Acta Psychiatr Scand 2009, 119:249-251. 10.1111/j.1600-0447.2009.01355.x, 19278392.
17. Lynch D, Laws KR, McKenna PJ. Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials. Psychol Med 2010, 40:9-24. 10.1017/S003329170900590X, 19476688.
18. Mendel R, Hamann J, Traut-Mattausch E, Buhner M, Kissling W, Frey D. "What would you do if you were me, doctor?": randomised trial of psychiatrists' personal v. professional perspectives on treatment recommendations. Br J Psychiatry 2010, 197:441-447. 10.1192/bjp.bp.110.078006, 21119149.
19. Owens DC. What CATIE Did: Some Thoughts on Implications Deep and Wide. Psychiatr Serv 2008, 59:530-533. 10.1176/appi.ps.59.5.530, 18451011.